Alzheimer Disease Clinical Trials in Toronto, Ontario

17 recruitingToronto, Ontario, Canada

Showing 117 of 17 trials

Recruiting
Phase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 2

Levetiracetam for Persons at Risk for Alzheimer's Disease

Hippocampal HyperactivationProdromal Alzheimer Disease
Sunnybrook Health Sciences Centre40 enrolled2 locationsNCT07477431
Recruiting
Phase 3

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Alzheimer Disease
Bristol-Myers Squibb352 enrolled157 locationsNCT07011732
Recruiting
Phase 3

Nabilone for Agitation Blinded Intervention Trial

Alzheimer DiseaseAgitation
Sunnybrook Health Sciences Centre112 enrolled6 locationsNCT04516057
Recruiting
Phase 2

Cannabidiol Medication Intervention Trial

Alzheimer Disease
Sunnybrook Health Sciences Centre40 enrolled5 locationsNCT06014424
Recruiting
Phase 2

Clinical Trial on Agitation in Alzheimer's Dementia

Alzheimer DiseaseAggressionAgitation,Psychomotor+2 more
IGC Pharma, LLC164 enrolled28 locationsNCT05543681
Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

DementiaMild Cognitive Impairment (MCI)Subjective Cognitive Impairment+7 more
McGill University1,573 enrolled19 locationsNCT03402919
Recruiting
Phase 2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+3 more
Sunnybrook Health Sciences Centre12 enrolled1 locationNCT07279740
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

Alzheimer DiseaseMajor Depressive DisorderMild Cognitive Impairment
Rotman Research Institute at Baycrest28 enrolled1 locationNCT03665831
Recruiting
Not Applicable

dTMS for Subjective Cognitive Decline

Alzheimer DiseaseSubjective Cognitive Decline
Rotman Research Institute at Baycrest30 enrolled1 locationNCT06095063
Recruiting
Not Applicable

rTMS for Apathy Clinical Trial

DementiaAlzheimer DiseaseMild Cognitive Impairment+3 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT05561205
Recruiting
Not Applicable

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

Obstructive Sleep ApneaAlzheimer DiseaseDementia With Lewy Bodies+4 more
Sunnybrook Health Sciences Centre200 enrolled1 locationNCT04335994
Recruiting
Not Applicable

Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease

Alzheimer Disease
University Health Network, Toronto6 enrolled1 locationNCT06936124
Recruiting
Not Applicable

Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease

DepressionAlzheimer Disease
Centre for Addiction and Mental Health50 enrolled1 locationNCT06732128
Recruiting
Not Applicable

Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

Alzheimer Disease
Baycrest42 enrolled1 locationNCT05508841
Recruiting
Not Applicable

Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease

Alzheimer Disease
Baycrest42 enrolled1 locationNCT05509387